Neena Bedi
Impact in
- Pharmaceutical Science top 1%
- Drug Solubulity and Delivery Systems
- Advanced Drug Delivery Systems
- Advancements in Transdermal Drug Delivery
- Molecular Medicine top 10%
Papers in
-
- Drug Solubulity and Delivery Systems 18
- Advanced Drug Delivery Systems 13
- Advancements in Transdermal Drug Delivery 7
- Co-authors
- Dilpreet Singh (23 shared papers)Ashok K. Tiwary (13 shared papers)Navjot Kaur (1 shared paper)Saroj Arora (18 shared papers)Simran Kaur (4 shared papers)Gurdeep Singh (8 shared papers)Atamjit Singh (10 shared papers)Shelly Khurana (1 shared paper)
- Journals
- Assay and Drug Development Technologies (3 papers)Current Drug Delivery (3 papers)Journal of Pharmaceutical Investigation (3 papers)Journal of Drug Delivery Science and Technology (3 papers)Therapeutic Delivery (2 papers)
- Partner nations
- IndiaUnited StatesSaudi Arabia
In The Last Decade
Neena Bedi
61 papers receiving 608 citations
Peers
Comparison fields: 5 of 96
- Pharmaceutical Science 268
- Molecular Medicine 37
- Toxicology 23
- Biomaterials 81
- Pharmacology 40
Countries citing papers authored by Neena Bedi
This map shows the geographic impact of Neena Bedi's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Neena Bedi with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Neena Bedi more than expected).
Fields of papers citing papers by Neena Bedi
This network shows the impact of papers produced by Neena Bedi. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Neena Bedi. The network helps show where Neena Bedi may publish in the future.
Co-authors
The 25 scholars most cited alongside Neena Bedi, linked wherever they have co-authored with each other. Click a name or a connecting line to browse the papers they share.
All Works
Showing the 20 most-cited of 69 papers — load more, or switch the sort, to bring in the rest.
| # | Work | ||
|---|---|---|---|
| 1 | 2017 | 88 | |
| 2 | 2018 | 56 | |
| 3 | 2018 | 50 | |
| 4 | 2022 | 32 | |
| 5 | 2021 | 28 | |
| 6 | FORMULATION AND EVALUATION OF MOUTH DISSOLVING TABLETS OF OXCARBAZEPINE | 2009 | 28 |
| 7 | 2023 | 26 | |
| 8 | 2022 | 23 | |
| 9 | 2021 | 21 | |
| 10 | 2022 | 18 | |
| 11 | 2022 | 18 | |
| 12 | 2018 | 16 | |
| 13 | 2021 | 14 | |
| 14 | 2018 | 13 | |
| 15 | 2020 | 12 | |
| 16 | Patenting and R&D in Indian Pharmaceutical Industry: Post-TRIPS Scenario | 2013 | 12 |
| 17 | 2019 | 10 | |
| 18 | 2023 | 9 | |
| 19 | 2023 | 8 | |
| 20 | 2021 | 8 |
About Neena Bedi
Neena Bedi is a scholar working on Pharmaceutical Science, Molecular Biology, Biomaterials, Organic Chemistry and Pharmacology, having authored 69 papers that have together received 633 indexed citations. Recurring topics across this work include Drug Solubulity and Delivery Systems (18 papers), Advanced Drug Delivery Systems (13 papers), Nanoparticle-Based Drug Delivery (7 papers), Advancements in Transdermal Drug Delivery (7 papers), Pharmacological Effects of Natural Compounds (6 papers), Bioactive Compounds and Antitumor Agents (5 papers), Dermatology and Skin Diseases (5 papers) and Analytical Methods in Pharmaceuticals (5 papers). The work is most often cited by research in Pharmaceutical Science (268 citations), Molecular Medicine (37 citations), Toxicology (23 citations), Biomaterials (81 citations) and Pharmacology (40 citations). Neena Bedi has collaborated with scholars based in India, United States and Saudi Arabia. Frequent co-authors include Dilpreet Singh, Ashok K. Tiwary, Navjot Kaur, Saroj Arora, Simran Kaur, Gurdeep Singh, Atamjit Singh, Shelly Khurana, Davinder Singh and Deepak N. Kapoor. Their work appears in journals such as Assay and Drug Development Technologies, Current Drug Delivery, Journal of Pharmaceutical Investigation, Journal of Drug Delivery Science and Technology and Therapeutic Delivery.
Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.